MYPLENZIA Trademark

Trademark Overview

On Monday, August 2, 2021, a trademark application was filed for MYPLENZIA with the United States Patent and Trademark Office. The USPTO has given the MYPLENZIA trademark a serial number of 90860372. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, July 16, 2024. This trademark is owned by STEALTH BIOTHERAPEUTICS INC.. The MYPLENZIA trademark is filed in the Pharmaceutical Products category with the following description:

Biopharmaceutical preparations for the prevention and treatment of cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities
myplenzia

General Information

Serial Number90860372
Word MarkMYPLENZIA
Filing DateMonday, August 2, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, July 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2022

Trademark Statements

Goods and ServicesBiopharmaceutical preparations for the prevention and treatment of cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTEALTH BIOTHERAPEUTICS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNeedham, MA 02494
Party NameSTEALTH BIOTHERAPEUTICS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNeedham, MA 02494

Trademark Events

Event DateEvent Description
Thursday, August 5, 2021NEW APPLICATION ENTERED
Tuesday, September 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 10, 2022ASSIGNED TO EXAMINER
Wednesday, January 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 4, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 4, 2022SOU EXTENSION 1 FILED
Tuesday, October 4, 2022SOU EXTENSION 1 GRANTED
Thursday, November 3, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 29, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 3, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 10, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 10, 2023SOU EXTENSION 2 FILED
Monday, April 10, 2023SOU EXTENSION 2 GRANTED
Wednesday, April 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 29, 2023SOU EXTENSION 3 FILED
Friday, September 29, 2023SOU EXTENSION 3 GRANTED
Tuesday, July 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 16, 2024SOU EXTENSION 5 FILED
Tuesday, July 16, 2024SOU EXTENSION 5 GRANTED
Friday, February 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 7, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 7, 2024SOU EXTENSION 4 FILED
Wednesday, February 7, 2024SOU EXTENSION 4 GRANTED

Related Keywords

myplenzia prevention treatment preparations disorders biological abnormalities diseases cellular ophthalmic cardiovascular